Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury

Sponsor
University of Utah (Other)
Overall Status
Completed
CT.gov ID
NCT03195179
Collaborator
(none)
200
1
68
2.9

Study Details

Study Description

Brief Summary

Pelvic fracture urethral injuries (PFUI) occur in up to 10% of pelvic fractures. It remains controversial whether initial urethral realignment after PFUI decreases rates of urethral obstruction and the need for subsequent urethral procedures.

The retrospective record review should determine the utility of acute urethral realignment after PFUI.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    A retrospective chart review to compare outcomes between urethral realignment (group 1) and suprapubic tube (SPT) placement (group 2). The comparison will be between two routinely practiced management approaches of urethral injury after pelvic fracture.

    Prior studies demonstrate urethral realignment is associated with a 15% to 50% reduction in urethral obstruction, however, it has also been associated with higher rates of incontinence and erectile dysfunction. Our hypothesis is that early realignment of traumatic urethral injuries after pelvic fracture lowers the incidence of complications like urethral strictures and subsequent need for surgeries.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    The Outcomes of Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury
    Actual Study Start Date :
    Jan 1, 2016
    Actual Primary Completion Date :
    Aug 31, 2021
    Actual Study Completion Date :
    Aug 31, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    Suprapubic tube placement

    Standard of care management for men with complete urethral injuries where a Foley catheter fails to be placed will have a suprapubic tube placed to manage the acute urethral injury. This is a standard of care approach and a retrospective review will be done on the patient record to determine outcomes.

    Urethral realignment

    Standard of care management for men with complete urethral injuries where a Foley catheter fails to be placed will undergo urethral realignment with a combined antegrade / retrograde approach within 7 days of injury. This is a standard of care approach and a retrospective review will be done on the patient record to determine outcomes.

    Outcome Measures

    Primary Outcome Measures

    1. Urethral obstruction [Through study completion, an average of 1 year]

      Rates of urethral obstruction identified by urethrogram or cystoscopy

    Secondary Outcome Measures

    1. Treatment rate for urethral obstruction [Through study completion, an average of 1 year]

      The rate of interventions for urethral obstruction after injury

    2. Urethroplasty complexity - gap length during urethroplasty [Through study completion, an average of 1 year]

      The gap between the 2 severed ends of the urethra

    3. Urethroplasty complexity - bulbar mobilization length during urethroplasty [Through study completion, an average of 1 year]

      The length of bulbar mobilization

    4. Urethroplasty complexity - corporal splitting during urethroplasty [Through study completion, an average of 1 year]

      The need to split the 2 corporal bodies

    5. Urethroplasty complexity - total obstruction of the urethra during urethroplasty [Through study completion, an average of 1 year]

      Finding the urethra was completely obstructed

    6. Urethroplasty complexity - urethral diverticulum discovered during urethroplasty [Through study completion, an average of 1 year]

      Finding a urethral diverticulum

    7. Urethroplasty complexity - urethral fistula present [Through study completion, an average of 1 year]

      Finding a urethral fistula

    8. Urethroplasty complexity - inferior pubectomy during urethroplasty [Through study completion, an average of 1 year]

      The need to remove the inferior portion of the symphysis pubis

    9. Urethroplasty complexity - total pubectomy during urethroplasty [Through study completion, an average of 1 year]

      The need to remove the complete symphysis pubis

    10. Erectile function- SHIM score [Through study completion, an average of 1 year]

      Erectile function measured by the Sexual Health Inventory for Men (SHIM)

    11. Erectile function - medical treatment rates [Through study completion, an average of 1 year]

      Measured by the need for pharmacologic treatment of erectile dysfunction

    12. Erectile function - surgical treatment rates [Through study completion, an average of 1 year]

      Rates of surgical treatment of erectile dysfunction

    13. Incontinence [Through study completion, an average of 1 year]

      Rates of surgical treatment of incontinence

    14. Post-injury complications [3 month period post acute urethral injury]

      Calvien-Dindo grading

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Male
    Inclusion Criteria:

    Men > 18 years old Blunt force trauma Presence of pelvic fracture Urethral injury Inability to pass a Foley catheter retrograde through the injury into the bladder

    Exclusion Criteria:

    Straddle type urethral injuries without a pelvic fracture Passage of a catheter successfully in a retrograde fashion

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Utah Salt Lake City Utah United States 84132

    Sponsors and Collaborators

    • University of Utah

    Investigators

    • Principal Investigator: Jeremy Myers, MD, University of Utah

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jeremy Myers, Associate Professor, University of Utah
    ClinicalTrials.gov Identifier:
    NCT03195179
    Other Study ID Numbers:
    • 00094160
    First Posted:
    Jun 22, 2017
    Last Update Posted:
    Oct 27, 2021
    Last Verified:
    Oct 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jeremy Myers, Associate Professor, University of Utah
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 27, 2021